These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 9169957

  • 1. Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment.
    Egberts AC, Lenderink AW, de Koning FH, Leufkens HG.
    J Clin Psychopharmacol; 1997 Jun; 17(3):149-55. PubMed ID: 9169957
    [Abstract] [Full Text] [Related]

  • 2. Antidepressant switching among adherent patients treated for depression.
    Marcus SC, Hassan M, Olfson M.
    Psychiatr Serv; 2009 May; 60(5):617-23. PubMed ID: 19411348
    [Abstract] [Full Text] [Related]

  • 3. An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
    Agius M, Gardner J, Liu K, Zaman R.
    Psychiatr Danub; 2010 Jun; 22(2):350-3. PubMed ID: 20562780
    [Abstract] [Full Text] [Related]

  • 4. An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
    Agius M, Gardner J, Liu K, Zaman R.
    Psychiatr Danub; 2010 Jun; 22(2):346-9. PubMed ID: 20562779
    [Abstract] [Full Text] [Related]

  • 5. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ.
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [Abstract] [Full Text] [Related]

  • 6. Antidepressant Treatment with Venlafaxine and Mirtazapine: no Effect on Serum Concentration of Vascular Endothelial Growth Factor (VEGF).
    Deuschle M, Gilles M, Scharnholz B, Kahl KG.
    Pharmacopsychiatry; 2015 Nov; 48(7):292-3. PubMed ID: 26190286
    [Abstract] [Full Text] [Related]

  • 7. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P, Ward HE, Tremblay P, Laberge L, Hébert C, Bergeron R.
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacological justification for the use of new antidepressant drugs].
    Nowakowska E, Kus K, Bobkiewicz-Kozłowska T.
    Pol Merkur Lekarski; 2002 Sep; 13(75):250-2. PubMed ID: 12474581
    [Abstract] [Full Text] [Related]

  • 9. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA, OPERATION Study Team.
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [Abstract] [Full Text] [Related]

  • 10. Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.
    Agius M, Gardner J, Liu K, Zaman R.
    Psychiatr Danub; 2010 Nov; 22 Suppl 1():S46-8. PubMed ID: 21057402
    [Abstract] [Full Text] [Related]

  • 11. Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators.
    Forns J, Pottegård A, Reinders T, Poblador-Plou B, Morros R, Brandt L, Cainzos-Achirica M, Hellfritzsch M, Schink T, Prados-Torres A, Giner-Soriano M, Hägg D, Hallas J, Cortés J, Jacquot E, Deltour N, Perez-Gutthann S, Pladevall M, Reutfors J.
    J Affect Disord; 2019 Apr 15; 249():242-252. PubMed ID: 30780117
    [Abstract] [Full Text] [Related]

  • 12. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.
    J Clin Psychopharmacol; 2003 Aug 15; 23(4):358-64. PubMed ID: 12920411
    [Abstract] [Full Text] [Related]

  • 13. Wuling Capsule for Major Depressive Disorder: A Meta-analysis of Randomised Controlled Trials.
    Zheng W, Zhang YF, Zhong HQ, Mai SM, Yang XH, Xiang YT.
    East Asian Arch Psychiatry; 2016 Sep 15; 26(3):87-97. PubMed ID: 27703096
    [Abstract] [Full Text] [Related]

  • 14. Somatic therapy for major depressive disorder: selection of an antidepressant.
    Preskorn SH, Burke M.
    J Clin Psychiatry; 1992 Sep 15; 53 Suppl():5-18. PubMed ID: 1522080
    [Abstract] [Full Text] [Related]

  • 15. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
    Kent JM.
    Lancet; 2000 Mar 11; 355(9207):911-8. PubMed ID: 10752718
    [Abstract] [Full Text] [Related]

  • 16. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
    Hummel J, Westphal S, Weber-Hamann B, Gilles M, Lederbogen F, Angermeier T, Luley C, Deuschle M, Kopf D.
    J Clin Psychiatry; 2011 Jul 11; 72(7):885-91. PubMed ID: 21294998
    [Abstract] [Full Text] [Related]

  • 17. New formulations of existing antidepressants: advantages in the management of depression.
    Norman TR, Olver JS.
    CNS Drugs; 2004 Jul 11; 18(8):505-20. PubMed ID: 15182220
    [Abstract] [Full Text] [Related]

  • 18. Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization.
    Sclar DA, Robison LM, Skaer TL, Galin RS, Legg RF, Nemec NL, Hughes TE, Buesching DP, Morgan M.
    J Int Med Res; 1995 Jul 11; 23(6):395-412. PubMed ID: 8746607
    [Abstract] [Full Text] [Related]

  • 19. Neural correlates of treatment outcome in major depression.
    Lisiecka D, Meisenzahl E, Scheuerecker J, Schoepf V, Whitty P, Chaney A, Moeller HJ, Wiesmann M, Frodl T.
    Int J Neuropsychopharmacol; 2011 May 11; 14(4):521-34. PubMed ID: 21205435
    [Abstract] [Full Text] [Related]

  • 20. Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
    Guo MY, Etminan M, Procyshyn RM, Kim DD, Samii A, Kezouh A, Carleton BC.
    J Clin Psychopharmacol; 2018 Aug 11; 38(4):349-356. PubMed ID: 29901567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.